A Phase IIIb Study to Investigate the Effect of Baxdrostat in Chinese Participants With Uncontrolled Hypertension.

NCT07686120 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

286

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncontrolled Hypertension

Interventions

DRUG: baxdrostat 2mg
DRUG: Placebo 2mg

Sponsor

AstraZeneca

Collaborators

[object Object]